C07K 14/34
From corynebacterium
Official title: from Corynebacterium (G)
C07K14/34 (From corynebacterium) appears on 467 US grants and 636 published applications in this corpus.
Search patents in C07K- Granted patents
- 467
- Published applications
- 636
- Assignees
- 249
- Inventors
- 1,129
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 11 | 0 |
| 1998 | 17 | 0 |
| 1999 | 10 | 0 |
| 2000 | 13 | 0 |
| 2001 | 3 | 1 |
| 2002 | 4 | 58 |
| 2003 | 4 | 31 |
| 2004 | 17 | 21 |
| 2005 | 23 | 36 |
| 2006 | 22 | 23 |
| 2007 | 18 | 44 |
| 2008 | 22 | 20 |
| 2009 | 9 | 21 |
| 2010 | 18 | 14 |
| 2011 | 14 | 12 |
| 2012 | 5 | 14 |
| 2013 | 17 | 16 |
| 2014 | 13 | 21 |
| 2015 | 18 | 21 |
| 2016 | 14 | 22 |
| 2017 | 16 | 22 |
| 2018 | 15 | 22 |
| 2019 | 14 | 23 |
| 2020 | 22 | 34 |
| 2021 | 25 | 17 |
| 2022 | 12 | 28 |
| 2023 | 19 | 29 |
| 2024 | 15 | 29 |
| 2025 | 19 | 30 |
| 2026 | 13 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- GlxR protein variant or threonine production method using same15 Sep 2026US 12,735,462 B2Cj Cheiljedang Corporation
- Method for secretory production of protein28 Jul 2026US 12,692,505 B2Ajinomoto Co., Inc.
- Recombinant strain producing L-lysine and construction methods therefor and use thereof28 Jul 2026US 12,692,506 B2Heilongjiang Eppen Biotech Co., Ltd.
- Microorganism having enhanced L-threonine producing ability and method for producing threonine using the same28 Jul 2026US 12,692,522 B2Cj Cheiljedang Corporation
- Recombinant organism and method9 Jun 2026US 12,649,911 B2Daesang Corporation
- Corynebacterium sp. microorganism producing l-glutamic acid and method for producing l-glutamic acid using same8 Oct 2026US 2026/0308647 A1Daesang Corporation
- Improved biotechnological process to produce guanidinoacetic acid (gaa) by targeted introduction or by increasing the activity of a transmembrane exporter protein17 Sep 2026US 2026/0275394 A1Evonik Operations GmbH
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
- Fusion protein, corresponding nucleic acid, in-vitro synthesis system, and preparation method10 Sep 2026US 2026/0265314 A1Kangma-Healthcode (Shanghai) Biotech Co., Ltd.
- Nanostructured proteins and uses thereof10 Sep 2026US 2026/0265317 A1
Most cited
By later US patents
- Hybrid molecules having translocation region and cell-binding region126US 5,668,255 ASeragen, Inc. · 1997
- Plasmid for production of CRM protein and diphtheria toxin123US 5,614,382 AAmerican Cyanamid Company · 1997
- Hybrid protein101US 4,675,382 APresident and Fellows of Harvard College · 1987
- Toxin conjugates95US 4,894,443 ACetus Corporation · 1990
- Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector91US 6,051,237 AThe Trustees of the University of Pennsylvania · 2000